GoodRx has officially entered the weight loss drug market by offering an exclusive discount on the once-daily oral medication Qsymia.

SANTA MONICA, Calif.--(BUSINESS WIRE)--GoodRx (Nasdaq: GDRX), the leading prescription savings platform in the U.S., ...

Approved users will be able to select an Affirm payment plan for select medications directly on the GoodRx platform.

Approved users will now be able to select an Affirm payment plan for select medications directly on the GoodRx platform GoodRx is launching this program with its partner pharmacies, including Hy ...

Qsymia’s manufacturer also released postmarketing data showing the oral therapy for weight loss was associated with ...

GoodRx (GDRX) announced that Qsymia is available for a low cash price in more than 70,000 retail pharmacy locations nationwide exclusively via ...

GoodRx is launching this program with its partner pharmacies, including Hy-Vee, a grocery retailer with a network of more than 275 retail pharmacies. Together, the companies are ensuring a ...

GoodRx shares rose 1.5% in premarket trading Tuesday after the healthcare company said it will offer a 30-day supply of oral ...

The introduction of this new e-commerce service is part of GoodRx’s broader strategy to further integrate health and wellness brands into its platform, streamlining the purchasing process and ...

( MENAFN - GlobeNewsWire - Nasdaq) NEW YORK, Oct. 31, 2024 (GLOBE NEWSWIRE) -- Kuehn Law, PLLC, a shareholder litigation law firm, is investigating whether certain officers and directors of GoodRx ...

Analyst Allen Lutz of Bank of America Securities maintained a Sell rating on GoodRx Holdings (GDRX – Research Report), retaining the ...